<h3></h3><h5>1、interquartile range 28-93:四分位数范围28-93.</h5>
<h5>2、the median age of all patients was 72 years (interquartile range 28-93):所有患者的中位年龄为72岁(四分位数范围为28-93)。</h5>
<h5>3、RDW ranged from 13.2 to 19.7:RDW范围从13.2到19.7</h5>
<h5>4、with a mean value of 15.9 ± 1.4:平均值为15.9±1.4</h5>
<h5>5、RBC indices:红细胞指数</h5>
<h5>6、stroke history:中风史.</h5>
<h5>7、95% confidence interval:95%置信区间.</h5>
<h5>8、For each 1% point increase in RDW value as a continuous variable, one-year all cause mortality risk was increased by 54% in univariate Cox proportional hazard analysis:将rdw值作为一个连续变量,每增加1%,单因素Cox比例风险分析就会使一年内所有原因的死亡风险增加54%。这里风险比HR:1.54,95%CI(1.21-1.94)</h5>
<h5>9、categorized variable:分类变量</h5><h5>10、 Cox proportional hazards analysis for all-cause mortality at 12 months:12个月全死因死亡率的Cox比例风险分析.</h5><h5>11、Additive prognostic value:加性预测值.</h5>
<h5>
</h5> <h3>1、Relation Between Red Cell Distribution Width and Clinical Outcomes After Acute Myocardial Infarction:急性心肌梗死后红细胞分布宽度与临床预后的关系
2、stable coronary disease:稳定型冠心病
3、adjusting for:调整为。
4、the adjusted hazard ratios:调整后的危险比率
5、the end point of heart failure:心力衰竭的终点
6、the routine blood cell count:常规血细胞计数。
7、during hospital course:住院期间。
8、In the present study we used a
prospective database:在本研究中,我们使用了一个前瞻性数据库。
9、The database provided an opportunity to study the relation between baseline RDW and changes in RDW with cardiovascular outcomes:数据库为研究基线rdw与rdw变化与心血管预后的关系提供了机会。
10、RDW is reported as a coefficient of variation (percentage) of red blood cell volume:据报道,rdw是红细胞体积的变异系数(年龄百分比)。
11、ambulatory subjects:流动学科
12、coronary artery disease risk factors:冠心病危险因素
13、health counseling:健康咨询
14、All patients were followed for 12 months after hospital discharge. The primary end point of the study was all-cause mortality after hospital discharge.:出院后随访12个月。研究的主要终点是出院后全因死亡。
15、were followed for:被跟踪
16、interstitial or alveolar edema:间质或肺泡水肿
17、national death registry:国家死亡登记处
18、interquartile ranges:四分位数范围
19、Changes in RDW at different time points were uated using a nonparametric approach to paired measurements (Wilcoxon signed-ranks test):用非参数方法对不同时间点的rdw的变化进行了评估(Wilcoxon符号秩检验)。
20、chi-square statistic:卡方统计
21、nonparametric approach:非参数统计方法
22、Wilcoxon signed-ranks tes:Wilcoxon符号秩检验
23、previous infarction:先前梗死,既往梗死
24、smoking status:吸烟状况
25、Killip class at admission:入院时killip分级等因素的调整。
26、thrombolytic therapy:溶栓治疗。
27、primary angioplasty:原发性血管成形术
28、antiplatelet agents:抗血小板药物
29、angiotensin-converting-enzyme:血管紧张素转换酶
30、left ventricular:左室
</h3> <h5>1、acute-phase reaction:急相反应
2、soluble transferrin receptor,:可溶性转铁蛋白受体
3、antecubital venipuncture:肘前静脉穿刺
4、citrate anticoagulated tubes:柠檬酸抗凝管
5、The samples were processed to obtain aliquots of serum and plasma, later stored at −70°C until further analysis.:样品经预提取后,保存在−70°C,待进一步分析。
6、skewed distributions,:倾斜分布
7、likelihood ratio tests:概度比检定
8、Diastolic blood pressure:舒张压
9、Positive coefficients:正系数
10、Red blood cell distribution width (RDW) is an
index of red blood cell variability:红细胞分布宽度(Rdw)是反映红细胞变异的一个指标。
11、In multivariate Cox proportional hazard models, each
1.0% increase in RDW value predicted an estimated
25% higher risk of mortality (P < 0.05):在多变量Cox比例风险模型中,RDW值每增加1.0%,估计死亡率就会高出25%(P<0.05)。 注意:这里风险比HR=1.25哦。
12、undergoing maintenance hemodialysis:维持性血液透析
13、Cardiovascular disease (CVD) is a significant
cause of morbidity:心血管疾病(CVD)是发病率的重要原因。
14、 10- to 40-folds:10至40倍。
15、major concerns:主要的担心
16 、metabolic milieu:代谢环境
17 、erythrocyte volume:红细胞体积
18、end-stage:终末期
19、were subjected to:受
20、Normalized protein equivalent of nitrogen appearance and uation of hemodialysis dose:正常蛋白质氮形态当量及血液透析剂量评价。
21、skewed distributions:偏态分布。
22、whichever occurred first.:以最先发生者为准。
23、Intact PTH:完整甲状旁腺激素
24、dialysis vintage:透析年份
25、Charlson comorbidity index scores:Charlson合并症指数评分
26、fatal arrhythmia:致命性心律失常
27、prospectively followed-up:前瞻性随访
28、
</h5><h3></h3>